Inhalational Anthrax
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers (NCT01952444) | Elusys Therapeutics | 2013-10-29 |
| Intramuscular Dose-Escalation Study With ETI-204 in Adult Volunteers (NCT01932437) | Elusys Therapeutics | 2013-07-26 |
| Safety, Tolerability and PK of Repeat Administration of Intravenous ETI-204 in Adult Volunteers (NCT01932242) | Elusys Therapeutics | 2013-07-23 |
| Safety, Tolerability, and PK of a Single Intravenous Dose of ETI-204 in Adult Volunteers (NCT01929226) | Elusys Therapeutics | 2013-07-09 |
Track Inhalational Anthrax automatically
Every clearance here is in the API, with alerts when new ones post.